Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.23 (
beta-galactosidase
)
14,648
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The Escherichia coli lac promoter mutation Pr115, an A X T to T X A transversion at +1 (the transcription initiation site of the lac wild-type and lac UV5 promoters), creates a new "-10 region"-like sequence starting at +1. We show that this mutation activates a new RNA polymerase binding site (
P115
) that overlaps with, and is shifted 12 base-pairs downstream from, the wild-type RNA polymerase binding site (P1). Nuclease S1 mapping studies and RNA polymerase protection experiments in vitro indicate that, in the absence of CAP-cAMP, this new site is used preferentially over the P1 site. In vivo,
beta-galactosidase
assays of the Pr115 mutation in combination with mutations of the P1 "-35 region" demonstrate that the P1 -35 region sequences are not involved in the interaction between RNA polymerase and
P115
in the absence of CAP-cAMP; therefore
P115
is an independent binding site. The presence of CAP-cAMP in vivo stimulates polymerase binding and initiation at P1, which serves to block polymerase from binding at
P115
.
...
PMID:Lactose promoter mutation Pr115 activates an overlapping promoter within the lactose control region. 241 53
Transposition of the P[1ArB] vector was used to generate three mutations inducing sterility in homozygous males: ms(3)P50, ms(3)P122, and ms(3)
P115
located within 67A4-B13, 92A2-14, and 75D regions on the polytene map. Staining for
beta-galactosidase
synthesized by P[1ArB] allowed us to study enhancer activity of these ms genes in the testicles. Their activity correlated to the presence of the YS arm but was little affected by the presence of YL arm of Y chromosome.
...
PMID:[Y chromosomal factor controls transcription of autosomal fertility genes in Drosophila melanogaster males]. 989 5